Greater China
Asia to play larger role in Eurazeo's second smart city fund
Asia is expected to feature more prominently – in terms of investors and investments – in Eurazeo’s second smart city venture capital fund, which has reached a first close of EUR80 million ($97 million).
Deal focus: CPE backs MicroPort's medical devices agenda
CPE has backed a string of spinouts from Chinese medical device manufacturer MicroPort Medical. MicroPort CardioFlow Medtech’s Hong Kong IPO represents its first liquidity event
China's Cloopen, Adagene complete strong US IPOs
Cloud services provider Cloopen and biotech developer Adagene, both backed by Sequoia Capital China, have raised a combined $460 million in their US IPOs.
China EV maker WM Motor gets $1.7b in debt financing
Chinese electric vehicle (EV) manufacturer WM Motor has secured RMB11.5 billion ($1.78 billion) in debt from domestic banks. It follows a RMB10 billion equity funding round featuring several government investors.
New Frontier to privatize US-listed China hospital business
The New Frontier Group-led consortium that acquired Chinese hospital operator United Family Healthcare (UFH) through a special purpose acquisition company (SPAC) in 2019 is now looking to take the US-listed business private at a valuation of around $1.6...
Cathay appoints executive president, makes partner promotions
Cathay Capital has announced a spate of global personnel appointments in private equity and venture capital, including the naming of Arthur Yeung as executive president.
China's Meishubao gets $40m Series D extension
Meishubao, a China-based online art education platform, has completed a Series D extension of more than $40 million that takes the overall funding round past $250 million.
Ethics in AI: Slippery slope
Concerns around artificial intelligence technology have extended from unauthorized surveillance to include healthcare and education. When does the ethical dilemma become an ESG sticking point for investors?
Sequoia, Tencent lead Series E for China's Miaoshou Doctor
Beijing Yuanxin Technology, operator of China-based online healthcare services platform Miaoshou Doctor, has raised RMB3 billion ($466 million) in Series E funding led by Sequoia Capital China and Tencent Holdings.
Eastern Bell seeks $600m for second US dollar fund
Eastern Bell Capital, a Chinese private equity firm that focuses on supply chains and logistics businesses, has set a target of $600 million for its second US dollar-denominated fund.
China's Yunqi promotes Yu Chen to partner
Chinese venture capital firm Yunqi Partners has promoted Yu Chen - who specializes in big data, cloud computing, autonomous driving, and robotics investments - to partner.
Brunei, CPE join Series C extension for China's Pony.ai
Chinese autonomous driving technology supplier Pony.ai has secured a Series C extension of $100 million featuring new investors Brunei Investment Agency and CPE. It takes the company’s total funding to date past $1.1 billion.
PE-backed Luckin files for bankruptcy in the US
Chinese coffee shop chain Luckin Coffee, which has several private equity backers, has filed for bankruptcy protection in the US to aid its restructuring efforts following the emergence of a sales fraud last year.
China robotics: Automation nation
China is a global leader in robot manufacturing, but only in areas characterized by high volumes and low technology value. Can more start-ups climb from medium-tech to hard-tech?
China vocational education provider gets $390m Series A
Fenbi, a China-based vocational education platform, has raised $390 million in a Series A round led by IDG Capital and Trustbridge Partners. Hony Capital also took part.
AVCJ Awards 2020: Special Achievement: Lip-Bu Tan
Recognized as one of the pioneers of venture capital in Asia, Walden International’s Lip-Bu Tan still gets a kick out of leveraging his years of experience to help nascent start-ups
China's Kuaishou surges on debut after $5.4b Hong Kong IPO
Kuaishou, a Chinese video-sharing and social networking platform backed by Tencent Holdings, 5Y Capital and DST Global, started trading at nearly three times its IPO price following a Hong Kong IPO that valued the company at HK$1.1 trillion ($142 billion)....
Tencent leads Series C for China gene sequencing player
Guangzhou-based precision diagnosis and gene sequencing company Vision Medicals has raised RMB200 million ($31 million) in Series C funding led by Tencent Holdings.
AVCJ Awards 2020: Responsible Investment: Canvest Environment
Olympus Capital has guided China’s Canvest Environment from polluting waste-to-energy minnow to category leader in operational scope and sustainability credentials
Q&A: Bain & Company's Henrik Naujoks
Henrik Naujoks, Bain & Company’s financial services lead for Asia, observes that investors must not ignore the increasing cohesion of the Greater Bay Area despite a relative lack of near-term gambits
Lilly Asia Ventures raises $1.35b for healthcare funds
Lilly Asia Ventures (LAV) has raised $1.35 billion for its latest healthcare fund, having introduced a $450 million opportunity vehicle that sits alongside a core pool of $900 million.
CDH leads $108m Series B for China baby care brand
Babycare, a Chinese baby products brand, has raised RMB700 million ($108 million) in Series B funding led by CDH Investments. Sequoia Capital China and Huaxing Growth Capital also participated.
Orchid, Matrix commit $100m to China gaming platform
Orchid Asia and Matrix Partners China have participated in a $100 million Series B round for Chinese gaming company Quwan Network Technology. Matrix led the Series A last year.
Sailing, GF lead $77m round for Chinese cognitive AI specialist
Dmai, a Chinese cognitive artificial intelligence (AI) platform also known as Anwu Zhineng, has raised RMB500 million ($77 million) in a Series A round led by Sailing Capital and GF Venture Capital.